...
首页> 外文期刊>Kurume Medical Journal >Evaluation of First-and Second-Generation Assays for Detection of Antibody to Hepatitis C Virus in non-A, non-B Chronic Liver DiseasesEvaluation of 1st and 2nd-Generation Assays in NANBH
【24h】

Evaluation of First-and Second-Generation Assays for Detection of Antibody to Hepatitis C Virus in non-A, non-B Chronic Liver DiseasesEvaluation of 1st and 2nd-Generation Assays in NANBH

机译:在非A,非B慢性肝病中检测丙型肝炎病毒抗体的第一代和第二代检测方法的评估NANBH中第一代和第二代检测方法的评估

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The positive rates of the second-generation enzyme-linked immunoassay (2nd-generation assay), and two first-generation immunoassays (C100-3 and KCL-163 assay) to test for anti-HCV antibodies in the serum of patients with non-A, non-B chronic liver disease were determined. The clinical usefulness of these assays was also evaluated. The group positive for the 2nd-generation assay alone was compared with that positive for the 2nd-generation and C100-3 assays with respect to the serum GPT levels determined simultaneously with the antibodies. The latter group showed slightly higher GPT levels. These findings suggest that the 2nd-generation assay is useful for the diagnosis of hepatitis C, and that C100-3 and KCL-163 assays are useful indicators of the activity of hepatic disorders.
机译:第二代酶联免疫测定(第二代测定)和两种第一代免疫测定(C100-3和KCL-163测定)的阳性率可检测非乙肝患者血清中的抗HCV抗体确定了A,非B慢性肝病。还评估了这些测定的临床实用性。就与抗体同时测定的血清GPT水平而言,将仅对第二代测定呈阳性的组与对于第二代和C100-3测定呈阳性的组进行比较。后一组显示GPT略高。这些发现表明第二代测定法可用于丙型肝炎的诊断,而C100-3和KCL-163测定法可作为肝功能异常的有用指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号